High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells

Journal of Virology

Volumn 80, Issue 18, 2006, Pages 8981-8988

  Yu, Julie H ^a   Schaffer, David V ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PEPTIDE; PEPTIDE LIBRARY; POL PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; GENE INSERTION; GENE LIBRARY; GENE VECTOR; GENETIC ANALYSIS; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LIFE CYCLE; MOUSE; MURINE LEUKEMIA VIRUS; NERVE CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN VARIANT; RETROVIRUS; TRANSPOSON; VIRAL GENE THERAPY; VIRION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS MUTANT; VIRUS STRAIN;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; GENE LIBRARY; HUMANS; LEUKEMIA VIRUS, MURINE; MOLECULAR SEQUENCE DATA; NEURONS; NUCLEAR LOCALIZATION SIGNALS; PROTEIN ENGINEERING; RATS;

HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA; MURINE LEUKEMIA VIRUS;

EID: 33748510172     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00615-06     Document Type: Article

References (56)

1. Anderson, J. L., and T. J. Hope. 2005. Intracellular trafficking of retroviral vectors: obstacles and advances. Gene Ther. 12:1667-1678.
2. Auerbach, M. R., C. Shu, A. Kaplan, and I. R. Singh. 2003. Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. Proc. Natl. Acad. Sci. USA 100:11678-11683.
3. Borel, F., F. B. Lacroix, and R. L. Margolis. 2002. Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis. J. Cell Sci. 115:2829-2838.
4. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
5. Bushman, F., M. Lewinski, A. Ciuffi, S. Barr, J. Leipzig, S. Hannenhalli, and C. Hoffmann. 2005. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3:848-858.
6. Caron, M. C., and M. Caruso. 2005. A nuclear localization signal in the matrix of spleen necrosis virus (SNV) does not allow efficient gene transfer into quiescent cells with SNV-derived vectors. Virology 338:292-296.
7. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, P. Bousso, F. L. Deist, and A. Fischer. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672.
8. Chen, L., D. M. Chetkovich, R. S. Petralia, N. T. Sweeney, Y. Kawasaki, R. J. Wentbold, D. S. Bredt, and R. A. Nicoll. 2000. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408:936-943.
9. Ciuffi, A., M. Llano, E. Poeschla, C. Hoffmann, J. Leipzig, P. Shinn, J. R. Ecker, and F. Bushman. 2005. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11:1287-1289.
10. Ciuffi, A., R. S. Mitchell, C. Hoffmann, J. Leipzig, P. Shinn, J. R. Ecker, and F. D. Bushman. 2006. Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol. Ther. 13:366-373.
11. Deminie, C. A., and M. Emerman. 1994. Functional exchange of an oncoretrovirus and a lentivirus matrix protein. J. Virol. 68:4442-4449.
12. Depienne, C., P. Roques, C. Creminon, L. Fritsch, R. Casseron, D. Dormont, C. Dargemont, and S. Benichou. 2000. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp. Cell Res. 260:387-395.
13. Dvorin, J. D., and M. H. Malim. 2003. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. Curr. Top. Microbiol. Immunol. 281:179-208.
14. Edelstein, M. L., M. R. Abedi, J. Wixon, and R. M. Edelstein. 2004. Gene therapy clinical trials worldwide 1989-2004-an overview. J. Gene Med. 6:597-602.
15. Engelman, A. 2003. The roles of cellular factors in retroviral integration. Curr. Top. Microbiol. Immunol. 281:209-238.
16. Fassati, A., and S. P. Goff. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-3635.
17. Fassati, A., and S. P. Goff. 1999. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Virol. 73:8919-8925.
18. Fassati, A., D. Gorlich, I. Harrison, L. Zaytseva, and J. M. Mingot. 2003. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. 22:3675-3685.
19. Fouchier, R. A., B. E. Meyer, J. H. Simon, U. Fischer, and M. H. Malim. 1997. HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:4531-4539.
20. Goff, S. P. 2004. Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. 38:61-85.
21. Goff, S. P. 2001. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J. Gene Med. 3:517-528.
22. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
23. Greenberg, K. P., S. F. Gellar, D. V. Schaffer, and J. G. Flannery. Submitted for publication.
24. Greger, J. G., R. A. Katz, K. Taganov, G. F. Rall, and A. M. Skalka. 2004. Transduction of terminally differentiated neurons by avian sarcoma virus. J. Virol. 78:4902-4906.
25. Hacein-Bey-Abina, S., C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255-256.
26. Hatziioannou, T., and S. P. Goff. 2001. Infection of nondividing cells by Rous sarcoma virus. J. Virol. 75:9526-9531.
27. Hung, D. T., T. F. Jamison, and S. L. Schreiber. 1996. Understanding and controlling the cell cycle with natural products. Chem. Biol. 3:623-639.
28. Jarrosson-Wuilleme, L., C. Goujon, J. Bernaud, D. Rigal, J. L. Darlix, and A. Cimarelli. 2006. Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J. Virol. 80:1152-1159.
29. Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith. 1984. A short amino acid sequence able to specify nuclear location. Cell 39:499-509.
30. Katz, R. A., J. G. Greger, K. Darby, P. Boimel, G. F. Rall, and A. M. Skalka. 2002. Transduction of interphase cells by avian sarcoma virus. J. Virol. 76:5422-5434.
31. Kukolj, G., R. A. Katz, and A. M. Skalka. 1998. Characterization of the nuclear localization signal in the avian sarcoma virus integrase. Gene 223:157-163.
32. Lai, K., B. K. Kaspar, F. H. Gage, and D. V. Schaffer. 2003. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat. Neurosci. 6:21-27.
33. Lee, S. K., K. Nagashima, and W. S. Hu. 2005. Cooperative effect of Gag proteins p12 and capsid during early events of murine leukemia virus replication. J. Virol. 79:4159-4169.
34. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
35. Lieber, A., M. A. Kay, and Z. Y. Li. 2000. Nuclear import of Moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells. J. Virol. 74:721-734.
36. Llano, M., M. Vanegas, O. Fregoso, D. Saenz, S. Chung, M. Peretz, and E. M. Poeschla. 2004. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 78:9524-9537.
37. Lois, C., E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872.
38. Martin, B. R., B. N. Giepmans, S. R. Adams, and R. Y. Tsien. 2005. Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity. Nat. Biotechnol. 23:1308-1314.
39. Mitchell, R. S., B. F. Beitzel, A. R. Schroder, P. Shinn, H. Chen, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
40. Mitrophanous, K., S. Yoon, J. Rohll, D. Patil, F. Wilkes, V. Kim, S. Kingsman, A. Kingsman, and N. Mazarakis. 1999. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6:1808-1818.
41. Nadler, S. G., D. Tritschler, O. K. Haffar, J. Blake, A. G. Bruce, and J. S. Cleaveland. 1997. Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences. J. Biol. Chem. 272:4310-4315.
42. Najmudin, S., M. L. Cote, D. Sun, S. Yohannan, S. P. Montano, J. Gu, and M. M. Georgiadis. 2000. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain. J. Mol. Biol. 296:613-632.
43. Parveen, Z., A. Krupetsky, M. Engelstadter, K. Cichutek, R. J. Pomerantz, and R. Dornburg. 2000. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat. Biotechnol. 18:623-629.
44. Parveen, Z., M. Mukhtar, M. Rafi, D. A. Wenger, K. M. Siddiqui, C. A. Siler, B. Dietzschold, R. J. Pomerantz, M. J. Schnell, and R. Dornburg. 2003. Cell-type-specific gene delivery into neuronal cells in vitro and in vivo. Virology 314:74-83.
45. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
46. Roth, M. J. 1991. Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J. Virol. 65:2141-2145.
47. Sastry, L., T. Johnson, M. J. Hobson, B. Smucker, and K. Cornetta. 2002. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9:1155-1162.
48. Seamon, J. A., K. S. Jones, C. Miller, and M. J. Roth. 2002. Inserting a nuclear targeting signal into a replication-competent Moloney murine leukemia virus affects viral export and is not sufficient for cell cycle-independent infection. J. Virol. 76:8475-8484.
49. Sherman, M. P., and W. C. Greene. 2002. Slipping through the door: HIV entry into the nucleus. Microbes Infect. 4:67-73.
50. Whittaker, G. R., M. Kann, and A. Helenius. 2000. Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16:627-651.
51. Yamashita, M., and M. Emerman. 2004. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78:5670-5678.
52. Yamashita, M., and M. Emerman. 2005. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog. 1:e18.
53. Yu, J. H., and D. V. Schaffer. 2006. Engineering retroviral and lentiviral vectors by selection of a novel peptide insertion library for enhanced purification. J. Virol. 80:3285-3292.
54. Yuan, B., A. Fassati, A. Yueh, and S. P. Goff. 2002. Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J. Virol. 76:10801-10810.
55. Yuan, B., X. Li, and S. P. Goff. 1999. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710.
56. Yueh, A., and S. P. Goff. 2003. Phosphorylated serine residues and an arginine-rich domain of the Moloney murine leukemia virus p12 protein are required for early events of viral infection. J. Virol. 77:1820-1829.